5-year survival and toxicity results of SIB radiotherapy in (very) high-risk prostate cancer

被引：0
|
作者：
Masson, I. [1 ]
Guerin-Charbonnel, C. [2 ]
Azria, D. [3 ]
Pommier, P. [4 ]
Mesgouez-Nebout, N. [5 ]
Giraud, P. [6 ]
Peiffert, D. [7 ]
Chauvet, B. [8 ]
Dudouet, P. [9 ]
Salem, N. [10 ]
Noel, G. [11 ]
Khalifa, J. [12 ]
Latorzeff, I. [13 ]
Mahe, M. A. [14 ]
Supiot, S. [15 ]
机构：
[1] Inst Cancerol Ouest Rene Gauducheau, Radiotherapy, Nantes, France
[2] Inst Cancerol Ouest Rene Gauducheau, Clin Trial Sponsor Unit Biometry, Nantes, France
[3] Inst Reg Canc Montpellier ICM, Federat Univ Oncol Radiotherapie FOROM, Montpellier, France
[4] Leon Berard Ctr, Radiotherapy, Lyon, France
[5] Inst Cancerol Ouest Paul Papin, Radiotherapy, Angers, France
[6] Georges Pompidou European Hosp, Radiotherapy, Paris, France
[7] Lorraine Canc Inst, Radiotherapy, Vandoeuvre Les Nancy, France
[8] Sainte Catherine Inst, Radiotherapy, Avignon, France
[9] Pont Chaume Clin, Radiotherapy, Montauban, Tarn & Garonne, France
[10] Paoli Calmettes Inst, Radiotherapy, Marseille, France
[11] Cancerol Inst Strasbourg Europe, Radiotherapy, Strasbourg, France
[12] Inst Univ Canc Toulouse Oncopole IUCT Oncopole, Radiotherapy, Toulouse, France
[13] Pasteur Clin, Radiotherapy, Toulouse, France
[14] Francois Baclesse Canc Ctr, Radiotherapy, Caen, France
[15] Inst Cancerol Ouest Rene Gauducheau, Radiotherapy, Nantes, France
来源：
RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1465
引用
收藏
页码：S1186 / S1187
页数：2
相关论文
共 50 条
  • [21] Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
    Saad, Akram
    Goldstein, Jeffrey
    Lawrence, Yaacov R.
    Spieler, Benjamin
    Leibowitz-Amit, Raya
    Berger, Raanan
    Davidson, Tima
    Urban, Damien
    Tsang, Lev
    Alezra, Dror
    Weiss, Ilana
    Symon, Zvi
    RADIATION ONCOLOGY, 2017, 12
  • [22] Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
    Akram Saad
    Jeffrey Goldstein
    Yaacov R. Lawrence
    Benjamin Spieler
    Raya Leibowitz-Amit
    Raanan Berger
    Tima Davidson
    Damien Urban
    Lev Tsang
    Dror Alezra
    Ilana Weiss
    Zvi Symon
    Radiation Oncology, 12
  • [23] Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer
    Fecteau, Ryan E.
    Koontz, Bridget F.
    Hoffman, Karen E.
    Halabi, Susan
    Howard, Lauren E.
    Anand, Monika
    George, Daniel J.
    Zhang, Tian
    Berry, William R.
    Lee, W. Robert
    Harrison, Michael R.
    Corn, Paul G.
    Armstrong, Andrew J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024,
  • [24] Sentinel Node-based Individualization of Intensity-modulated Pelvic radiation of High-Risk Prostate cancer: 5-Year Results
    Mueller, A. -C.
    Eckert, F.
    Paulsen, F.
    Bamberg, M.
    Stenzl, A.
    Schilling, D.
    Alber, M.
    Bares, R.
    Belka, C.
    Ganswindt, U.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 81 - 81
  • [25] HIGH-DOSE-RATE (HDR) BRACHYTHERAPY WITH EXTERNAL BEAM RADIOTHERAPY FOR LOCALIZED HIGH RISK PROSTATE CANCER: 5-YEAR RESULTS IN 141 PATIENTS
    Masahito, K.
    Miki, K.
    Aoki, M.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S382 - S382
  • [26] 5-year outcomes after prostatectomy or radiotherapy for prostate cancer
    Strnad, V
    Sauer, R
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 (03) : 205 - 205
  • [27] Online adaptive radiotherapy potentially reduces toxicity for high-risk prostate cancer treatment
    Christiansen, Rasmus Lubeck
    Dysager, Lars
    Hansen, Christian Ronn
    Jensen, Henrik Robenhagen
    Schytte, Tine
    Nyborg, Christina Junker
    Bertelsen, Anders Smedegaard
    Agergaard, Soren Nielsen
    Mahmood, Faisal
    Hansen, Steinbjorn
    Hansen, Olfred
    Brink, Carsten
    Bernchou, Uffe
    RADIOTHERAPY AND ONCOLOGY, 2022, 167 : 165 - 171
  • [28] Re: Survival After Radical Prostatectomy Versus Radiation Therapy in High-risk and Very High-risk Prostate Cancer
    Pushkar, Dmitry
    Govorov, Alexander
    EUROPEAN UROLOGY, 2022, 82 (01) : 144 - 145
  • [29] IMAGE-GUIDED INTENSITY MODULATED HYPOFRACTIONATED RADIOTHERAPY IN HIGH-RISK PROSTATE CANCER PATIENTS: TOXICITY AND PRELIMINARY RESULTS
    Valeriani, Maurizio
    Bonome, Paolo
    Osti, Mattia Falchetto
    De Sanctis, Vitaliana
    Bracci, Stefano
    Agolli, Linda
    Enrici, Riccardo Maurizi
    ANTICANCER RESEARCH, 2015, 35 (06) : 3702 - 3702
  • [30] Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer
    Di Muzio, Nadia Gisella
    Deantoni, Chiara Lucrezia
    Brombin, Chiara
    Fiorino, Claudio
    Cozzarini, Cesare
    Zerbetto, Flavia
    Mangili, Paola
    Tummineri, Roberta
    Dell'Oca, Italo
    Broggi, Sara
    Pasetti, Marcella
    Chiara, Anna
    Rancoita, Paola Maria Vittoria
    Del Vecchio, Antonella
    Di Serio, Mariaclelia Stefania
    Fodor, Andrei
    CANCERS, 2021, 13 (19)
12345